Navigation Links
Solera Holdings, Inc. Appoints Jason Brady as General Counsel
Date:3/11/2008

SAN DIEGO, March 11 /PRNewswire-FirstCall/ -- Solera Holdings, Inc. (NYSE: SLH), the leading global provider of software and services for the automobile insurance claims processing industry, today announced the appointment of Jason Brady as Senior Vice President and General Counsel, responsible for the Company's global legal organization, including corporate compliance and governance and mergers and acquisitions.

Brady has more than 12 years of relevant law experience, and in past positions has been responsible for SEC reporting and compliance, corporate transactions, corporate governance, litigation, commercial collaborations, intellectual property matters and employment matters.

He previously served as Vice President, General Counsel and Corporate Secretary at Xenogen Corporation, a publicly traded biotechnology company that was sold to Caliper Life Sciences, Inc. Prior to that, Brady held senior legal positions with Abbott Diabetes Care, TheraSense, Inc., Ensera, Inc. and AllAdvantage. At Ensera, he gained valuable insight into the software and services segment of the automobile insurance claims processing industry, working closely with Solera's founder, chairman and CEO, Tony Aquila, to build the business as a member of Ensera's senior management team. Jason started his career at the law firm of Wilson Sonsini Goodrich & Rosati in Palo Alto, California.

"I am looking forward to working with Jason Brady again as his legal counsel was instrumental at Ensera," said Aquila. "With Solera's May 2007 IPO and NYSE listing, and international business presence, the legal function remains critical to our success worldwide. Jason has a strong track record of achievement, and I intend to leverage his skills and expertise as part of our business and geographic expansion objectives."

Brady, 39, holds a Bachelor of Arts degree from the University of California at Los Angeles and a Juris Doctor degree from Santa Clara University School of Law. He is based in Solera's San Diego office and will report directly to Aquila.

About Solera

Solera is the leading global provider of software and services for the automobile insurance claims processing industry. Solera is active in over 50 countries across six continents. The Solera companies include Audatex in the United States, Canada, and in more than 45 additional countries, Informex in Belgium, Sidexa in France, ABZ in the Netherlands, Hollander serving the North American recycling market, and IMS providing medical review services. For more information, please refer to the Company's website at http://www.solerainc.com.

Contacts:

Investor Relations:

Kamal Hamid

Solera Holdings, Inc.

858-946-1676

kamal.hamid@audatex.com

Media Relations:

Kendra DeWitt

Solera Holdings, Inc.

858-946-1453

kendra.dewitt@audatex.com


'/>"/>
SOURCE Solera Holdings, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Duane Reade Holdings, Inc. to Report Fourth Quarter and Full Year 2007 Financial Results
2. Whitemark Homes Signs Letter of Intent to Acquire Metiscan Holdings, Inc.
3. Vallon Holdings, LLC Launches New Subsidiary Focused on Contract Resources for the Minneapolis-St. Paul Life Science Industry
4. NightHawk Radiology Holdings, Inc. Announces Board Member Departure
5. NightHawk Radiology Holdings, Inc. to Speak at the Cowen and Company 28th Annual Health Care Conference on March 18, 2008
6. Lixte Biotechnology Holdings, Inc. Announces Further Developments Regarding the Anti-Cancer Activity of Its Patent-Pending Proprietary Compounds
7. Platinum Underwriters Holdings, Ltd. Reports Record Fourth Quarter and Year Ended December 31, 2007 Financial Results
8. NightHawk Radiology Holdings, Inc. Announces Fourth Quarter and Full-Year 2007 Results; Updates 2008 Guidance
9. Berkery Noyes Represented The Riverside Company on the Sale of HCPro Holdings, Inc. to Halyard Capital, LLC
10. NightHawk Radiology Holdings, Inc. Announces Time Change for Fourth Quarter and Full-Year 2007 Earnings Conference Call
11. MBF Healthcare Acquisition Corp. to Host Investor Conference Call to Review Stock Purchase Agreement Signed With Critical Homecare Solutions Holdings, Inc.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/5/2016)... York, New York (PRWEB) , ... February 05, 2016 , ... ... life? The answer may be at the tips of your toes. Foot massage, whether ... as well as pure comfort and relaxation. The American Board of Multiple Specialties ...
(Date:2/5/2016)... ... February 05, 2016 , ... ... franchises from across the country gathered at the La Valencia Hotel in San ... PROSHRED Chicago was named the year’s most outstanding franchise, walking away with ...
(Date:2/5/2016)... ... 05, 2016 , ... Pivot Point Consulting, a leading national ... & Services for HIT Implementation Support & Staffing report with an outstanding score ... by healthcare executives, managers and clinicians representing over 4,500 hospitals and 2,500 clinics. ...
(Date:2/5/2016)... (PRWEB) , ... February 05, 2016 , ... Colorize ... from on one drop zone to the next using Colorize's dynamic moving camera. Colorize ... project. This package includes a 3D slideshow environment with 1 to 5 focus points ...
(Date:2/5/2016)... ... 05, 2016 , ... Calls Blacklist has just been updated by mobile app ... the developer has fixed known bugs within the app. Calls Blacklist allows its users ... not consuming any of their device’s battery power or memory. It provides a powerful ...
Breaking Medicine News(10 mins):
(Date:2/4/2016)... Feb. 4, 2016  SciClone Pharmaceuticals, Inc. (NASDAQ: ... has entered into a settlement agreement with the ... resolving the SEC,s investigation into possible violations of ... terms of the settlement agreement, SciClone has agreed ... disgorgement, pre-judgment interest and a penalty.  This payment ...
(Date:2/4/2016)... -- Global Immunology Market to 2022 - Large ... growth Summary Immune-mediated inflammatory diseases are ... affect 5–7% of western populations. Although they are ... key patient demographics, they are pathophysiologically linked, being ... inappropriate immune response. Generally, disease-modifying anti-rheumatic drugs, a ...
(Date:2/4/2016)...  Aethlon Medical, Inc. (Nasdaq: AEMD ), ... treat life-threatening diseases, today announced results for the ... 2015. --> --> ... our last quarterly call, we strategically advanced pre-clinical ... to establish the Aethlon Hemopurifier® as a leading ...
Breaking Medicine Technology: